Sign in

CIK 0001651308 · Large accelerated filer

BeOne Medicines Ltd.

Sign in to watch
Ticker
BEIGF
Exchange
Nasdaq, OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
operating
EIN
981209416
Phone
41-616851900
Business address
C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, Switzerland, 4051
Former names
BeiGene, Ltd.

Securities

  • ONC American Depositary Shares Nasdaq
  • BEIGF Common stock OTC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$48,487,541
in 9 filings, $47.8M under 10b5-1 plans

Net −$48,487,541. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-06-15 BAKER BROS. ADVISORS LP Director Grant or award · Share Option (Right to Buy) +53,950 53,950
2023-06-15 BAKER BROS. ADVISORS LP Director Grant or award · Share Option (Right to Buy) +53,950 53,950
2023-06-15 Yi Qingqing Director Grant or award +12,922 29,614
2023-06-15 Yi Qingqing Director Grant or award · Share Option (Right to Buy) +26,975 26,975
2023-06-14 HHLR ADVISORS, LTD. 10% owner Sale −273,728 $207.72 $56.9M 142,888,241
2023-06-13 HHLR ADVISORS, LTD. 10% owner Sale −611,000 $211.45 $129.2M 143,475,369
2023-06-13 HHLR ADVISORS, LTD. 10% owner Sale −313,400 $128.43 $40.3M 143,161,969
2023-06-12 HHLR ADVISORS, LTD. 10% owner Sale −281,400 $130.83 $36.8M 145,055,181
2023-06-12 HHLR ADVISORS, LTD. 10% owner Sale −968,812 $213.91 $207.2M 144,086,369
2023-06-09 HHLR ADVISORS, LTD. 10% owner Sale −213,700 $130.35 $27.9M 145,665,533
2023-06-09 HHLR ADVISORS, LTD. 10% owner Sale −328,952 $217.02 $71.4M 145,336,581
2023-06-08 HHLR ADVISORS, LTD. 10% owner Sale −1,163,825 $218.14 $253.9M 145,879,233
2023-06-07 Wang Lai Global Head of R&D Sale −74 $223.23 $17K 388
2023-06-07 Wang Lai Global Head of R&D Sale −161 $224.04 $36K 227
2023-06-07 Wang Lai Global Head of R&D Sale −111 $225.27 $25K 116
2023-06-07 Wang Lai Global Head of R&D Sale −116 $226.15 $26K 0
2023-06-07 Wu Xiaobin President, COO & GM China Sale −531 $223.23 $119K 2,760
2023-06-07 Wu Xiaobin President, COO & GM China Sale −1,147 $224.04 $257K 1,613
2023-06-07 Wu Xiaobin President, COO & GM China Sale −789 $225.27 $178K 824
2023-06-07 Wu Xiaobin President, COO & GM China Sale −824 $226.15 $186K 0

Page 44 of 71 · 1,406 trades